BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 5377374)

  • 21. [Relations between colpocytological patterns in pregnancy and determination of human placental lactogen].
    Riva G; Cena C; Patti M
    Atti Accad Med Lomb; 1975; 30(1-3):29-33. PubMed ID: 1234850
    [No Abstract]   [Full Text] [Related]  

  • 22. Assessment of placental function.
    Symonds M
    Midwife Health Visit Community Nurse; 1975 Jun; 11(6):173, 175, 177. PubMed ID: 1040116
    [No Abstract]   [Full Text] [Related]  

  • 23. Prospects of the laboratory diagnosis of intrauterine foetal distress.
    Donát J; Jirkalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):569-622. PubMed ID: 6972081
    [No Abstract]   [Full Text] [Related]  

  • 24. [Placental lactogen hormone and the oxytocin test. Comparison between 2 diagnostic methods for placental insufficiency].
    Sanchez-Ramos J; Del Olmo J; Botella-Llusia J
    J Gynecol Obstet Biol Reprod (Paris); 1974 Sep; 3(6):895-901. PubMed ID: 4470760
    [No Abstract]   [Full Text] [Related]  

  • 25. [Monitoring of high-risk pregnancies (author's transl)].
    Davi D; Vernotico V; Bottoni A; Vallini A; Candi L; Zanella B
    Quad Sclavo Diagn; 1978 Dec; 14(4):468-85. PubMed ID: 757621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum human placental lactogen (HPL) in pregnancy assessment (selected case illustrations).
    Harris P; Malvesta R
    J Maine Med Assoc; 1974 Dec; 65(12):308-10. PubMed ID: 4443642
    [No Abstract]   [Full Text] [Related]  

  • 27. Human placental lactogen and ultrasonic screening for the detection of placental insufficiency.
    Kullander S; Marsál K; Persson PH
    Contrib Gynecol Obstet; 1982; 9():129-44. PubMed ID: 6754247
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of biochemical indices in the management of high risk obstetric patients.
    Tulchinsky D
    Clin Perinatol; 1980 Sep; 7(2):413-21. PubMed ID: 7438673
    [No Abstract]   [Full Text] [Related]  

  • 29. Serial estimation of human placental lactogen, estriol, and pregnanediol in pregnancy correlated with whole organ section of placenta.
    Samaan NA; Gallager HS; McRoberts WA; Faris AM
    Am J Obstet Gynecol; 1971 Jan; 109(1):63-73. PubMed ID: 5538972
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnostic value of serial determination of estriol and HPL in plasma and of total estrogens in 24-h-urine compared to single values for diagnosis of fetal danger].
    von Holst T; Klinga K; Runnebaum B
    Arch Gynecol; 1979 Jul; 228(1-4):230-1. PubMed ID: 485319
    [No Abstract]   [Full Text] [Related]  

  • 31. The oxytocin challenge test, plasma estriol, and human placental lactogen values in high-risk pregnancy.
    Bashore RA; Staisch KJ; Westlake JR
    Trans Pac Coast Obstet Gynecol Soc; 1979; 46():13-9. PubMed ID: 542969
    [No Abstract]   [Full Text] [Related]  

  • 32. [Modern hormonal methods used in the diagnosis of fetal distress].
    Markovski N; Trepechov S; Zhekova V
    Akush Ginekol (Sofiia); 1977; 16(4):267-73. PubMed ID: 333973
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cytological picture of feto-placental disorders in threatened pregnancies].
    Zidovsky J; Hodr J; Vedra B; Stembera Z; Jungmannovă C
    Cesk Gynekol; 1972 Jun; 37(5):299-300. PubMed ID: 5043738
    [No Abstract]   [Full Text] [Related]  

  • 34. Doppler assessment of the umbilical circulation.
    Cook CM; Connelly AJ; Trudinger BJ
    Semin Ultrasound CT MR; 1989 Oct; 10(5):417-27. PubMed ID: 2697354
    [No Abstract]   [Full Text] [Related]  

  • 35. [DHA-S-loading test for assessing placentar function with radioimmunologic determination of plasma estrogens (author's transl)].
    Strecker JR; Lauritzen C
    Z Geburtshilfe Perinatol; 1974 Aug; 178(4):254-64. PubMed ID: 4280663
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormonal early diagnosis of fetal risk in pregnancy].
    Keller PJ; Gerber C
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):973-9. PubMed ID: 5133081
    [No Abstract]   [Full Text] [Related]  

  • 37. [Significance of composite scoring of biochemical monitoring in fetal distress].
    Zhu FQ
    Zhonghua Fu Chan Ke Za Zhi; 1991 May; 26(3):136-9, 187. PubMed ID: 1874054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The value of luminescent colpocytology in determining fetal condition and placental function].
    Lopatchenko OI; Levinson LL
    Vopr Okhr Materin Det; 1971 Aug; 16(8):72-6. PubMed ID: 5151941
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Hormonal control of high risk pregnancy].
    Dittmar FW; Tykal P
    Arch Gynakol; 1973 Sep; 214(1):207-8. PubMed ID: 4273328
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved hemagglutination-inhibition assay: clinical application to measurement of human placental lactogen.
    Gusdon JP
    Obstet Gynecol; 1969 Mar; 33(3):397-403. PubMed ID: 5776090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.